US equities
|
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
META
$728.08
▲+0.00%
JNJ
$256.03
▲+0.00%
AMD
$633.91
▲+0.00%
NVDA
$233.95
▲+0.00%
TSLA
$370.59
▲+0.00%
SNDK
$1,719.99
▲+0.00%
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
META
$728.08
▲+0.00%
JNJ
$256.03
▲+0.00%
AMD
$633.91
▲+0.00%
NVDA
$233.95
▲+0.00%
TSLA
$370.59
▲+0.00%
SNDK
$1,719.99
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Delcath Systems, Inc. - Common Stock
(NQ:
DCTH
)
15.13
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Delcath Systems, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Looking Into Delcath Systems's Return On Capital Employed
↗
June 02, 2021
During Q1, Delcath Systems (NASDAQ:DCTH) brought in sales totaling $388.00 thousand. However, earnings decreased 8.25%, resulting in a loss of $6.85 million. In Q4, Delcath...
Via
Benzinga
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
↗
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
Earnings Scheduled For May 11, 2021
↗
May 11, 2021
Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is...
Via
Benzinga
Delcath Systems: Q1 Earnings Insights
↗
May 11, 2021
Shares of Delcath Systems (NASDAQ:DCTH) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share rose 99.04% over the past year to ($1.04...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >